跳至主要内容
临床试验/IRCT20200407046978N1
IRCT20200407046978N1招募中未知

Effect of intravitreal bevacizumab (Avastin®) plus vitamin D supplementation on diabetic macular edema in vitamin D deficient patients

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients with diabetes mellitus type 2 and diabetic macular edema
  • Central macular thickness equal and greater than 300 micron
  • Corrected distance visual acuity of greater than 0.1 LogMAR

排除标准

  • History of any intraocular surgery (except uncomplicated cataract surgery which at least 6 months are passed)
  • History of intravitreal injection of bevacizumab, other anti-VEGFs and steroid within 3 past months
  • Epiretinal membrane or vitreomacular traction
  • History of retinal vascular accidents
  • History of uveitis
  • Pregnant or breastfeeding women
  • Using vitamin supplementation
  • Not taking vitamin D supplementation based on the study protocol during follow up period
  • Patients with severe vitamin D deficiency (<10 ng/ml)
  • Macular disease and consequent visual impairment due to causes other than diabetic macular edema
  • Hypercalcemia and hyperphosphatemia
  • Serum creatinin > 3 mg/dl

研究者

相似试验